Weiyuan Biotechnology Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $13.9M

  • Investors
  • 7

Weiyuan Biotechnology General Information

Description

Provider of enzyme evolution and high-throughput screening technologies intended to enhance the production of chiral compounds, active natural product extraction and rapid construction of recombinant cell factories. The company's biotechnologies are based on the intelligent evolution of enzymes and high-throughput screening of strains, as well as precision analysis and intelligent prediction techniques, providing businesses in the biotechnology sector with improved production of chiral compounds, increased efficiency in the extraction of active natural products and faster construction of recombinant cell factories.

Contact Information

Website
www.wybio.cc
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 401, Building 7, Number 611, Dongguan Road
  • Puyan Street, Binjiang District
  • Hangzhou, Zhejiang 310000
  • China
+86 0571
Primary Industry
Biotechnology
Corporate Office
  • Room 401, Building 7, Number 611, Dongguan Road
  • Puyan Street, Binjiang District
  • Hangzhou, Zhejiang 310000
  • China
+86 0571

Weiyuan Biotechnology Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Weiyuan Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 19-Aug-2025 $13.9M Completed Generating Revenue
3. Early Stage VC 27-Apr-2025 Completed Generating Revenue
2. Early Stage VC 27-Jun-2024 $1.42M Completed Generating Revenue
1. Seed Round 05-Jun-2023 $1.42M $1.42M Completed Startup
To view Weiyuan Biotechnology’s complete valuation and funding history, request access »

Weiyuan Biotechnology Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dalton Venture Venture Capital Minority
Roton Capital Venture Capital Minority
Hangzhou Oufang Venture Capital Management Growth/Expansion Minority
Silicon Valley Real Stone Asset Management Asset Manager Minority
Xinghua Dingli Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Weiyuan Biotechnology FAQs

  • When was Weiyuan Biotechnology founded?

    Weiyuan Biotechnology was founded in 2023.

  • Where is Weiyuan Biotechnology headquartered?

    Weiyuan Biotechnology is headquartered in Hangzhou, China.

  • What industry is Weiyuan Biotechnology in?

    Weiyuan Biotechnology’s primary industry is Biotechnology.

  • Is Weiyuan Biotechnology a private or public company?

    Weiyuan Biotechnology is a Private company.

  • What is Weiyuan Biotechnology’s current revenue?

    The current revenue for Weiyuan Biotechnology is .

  • How much funding has Weiyuan Biotechnology raised over time?

    Weiyuan Biotechnology has raised $15.4M.

  • Who are Weiyuan Biotechnology’s investors?

    Dalton Venture, Roton Capital, Hangzhou Oufang Venture Capital Management, Silicon Valley Real Stone Asset Management, and Xinghua Dingli Capital are 5 of 7 investors who have invested in Weiyuan Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process